These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33284795)

  • 1. In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species.
    Delgado Blanco J; Hernandez-Alias X; Cianferoni D; Serrano L
    PLoS Comput Biol; 2020 Dec; 16(12):e1008450. PubMed ID: 33284795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
    Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
    Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
    Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP
    J Virol; 2022 Sep; 96(17):e0025622. PubMed ID: 36000847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
    Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
    Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
    Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
    Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2.
    Shu CJ; Huang X; Tang HH; Mo DD; Zhou JW; Deng C
    Zool Res; 2021 Mar; 42(2):170-181. PubMed ID: 33738989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
    Wan Y; Shang J; Graham R; Baric RS; Li F
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31996437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
    Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.
    Mou H; Quinlan BD; Peng H; Liu G; Guo Y; Peng S; Zhang L; Davis-Gardner ME; Gardner MR; Crynen G; DeVaux LB; Voo ZX; Bailey CC; Alpert MD; Rader C; Gack MU; Choe H; Farzan M
    PLoS Pathog; 2021 Apr; 17(4):e1009501. PubMed ID: 33836016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2.
    Huang X; Zhang C; Pearce R; Omenn GS; Zhang Y
    J Proteome Res; 2020 Dec; 19(12):4844-4856. PubMed ID: 33175551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features.
    Hassan SS; Ghosh S; Attrish D; Choudhury PP; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Uversky VN; Seyran M; Pizzol D; Adadi P; Soares A; El-Aziz TMA; Kandimalla R; Tambuwala MM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Á; Chauhan G; Palu G; Brufsky AM
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain.
    Low-Gan J; Huang R; Kelley A; Jenkins GW; McGregor D; Smider VV
    Biochem J; 2021 Oct; 478(19):3671-3684. PubMed ID: 34558627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans.
    Xue X; Shi J; Xu H; Qin Y; Yang Z; Feng S; Liu D; Jian L; Hua L; Wang Y; Zhang Q; Huang X; Zhang X; Li X; Chen C; Guo J; Tang W; Liu J
    Sci Rep; 2021 Feb; 11(1):3187. PubMed ID: 33542420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
    Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
    Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
    Lata S; Akif M
    J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants.
    da Costa CHS; de Freitas CAB; Alves CN; Lameira J
    Sci Rep; 2022 May; 12(1):8540. PubMed ID: 35595778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
    Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
    J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies.
    Samanta A; Alam SSM; Ali S; Hoque M
    Funct Integr Genomics; 2023 Jan; 23(1):36. PubMed ID: 36631570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.